SCHEMBL13720522

SCHEMBL13720522

CC(C)(C)OC(=O)NCC[C@]1(c2ccccc2)C[C@H]1COCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.43
CTSS P25774 1/20 0.41
PPARA Q07869 2/20 0.41
SYK P43405 1/20 0.41
SIGMAR1 Q99720 3/20 0.40
NPFFR1 Q9GZQ6 1/20 0.38
NPFFR2 Q9Y5X5 1/20 0.38
PPARG P37231 1/20 0.38
KLK7 P49862 3/20 0.38
KLK5 Q9Y337 3/20 0.38
MAPT P10636 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BCHE P06276 1/20 0.37
CNR2 P34972 1/20 0.37
NAMPT P43490 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA7 P43166 1/20 0.37
CA14 Q9ULX7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13720294 1.00 IDO1 (0.43) IDO1CTSSPPARASYKSIGMAR1
SCHEMBL13720464 0.89 SYK (0.45) IDO1CTSSPPARASYKSIGMAR1
SCHEMBL13720411 0.89 SYK (0.45) IDO1CTSSPPARASYKSIGMAR1
SCHEMBL13720143 0.89 SYK (0.45) IDO1CTSSPPARASYKSIGMAR1
SCHEMBL13720351 0.85 IDO1 (0.42) IDO1SIGMAR1NPFFR1NPFFR2BCHE
SCHEMBL6173847 0.84 LMNA (0.42) IDO1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL13720265 0.79 IDO1 (0.41) IDO1SIGMAR1NPFFR1NPFFR2BCHE
SCHEMBL13720690 0.79 IDO1 (0.41) IDO1SIGMAR1NPFFR1NPFFR2BCHE
SCHEMBL4028380 0.79 L3MBTL1 (0.43) CTSSPPARAL3MBTL1
SCHEMBL4029654 0.79 L3MBTL1 (0.43) CTSSPPARAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
EP-1569934-B1 CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2008-01-23 EP disclosed